Description

AC-VEID-CHO (TFA) is a peptide-derived caspase inhibitor and has potency of inhibition for Caspase-6, Caspase-3 and Caspase-7 with IC50 values of 16.2 nM, 13.6 nM and 162.1 nM, respectively. AC-VEID-CHO (TFA) can be used for the research of neurodegenerative conditions including Alzheimer’s and Huntington’s disease[1].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–Neuroscience-Neurodegeneration–C24H37F3N4O11—-[1]Robert Mintzer, et al. A whole cell assay to measure caspase-6 activity by detecting cleavage of lamin A/C. PLoS One. 2012;7(1):e30376.—-614.57–98.0–OC(C(F)(F)F)=O.CC[C@@H]([C@@H](C(N[C@H](C=O)CC(O)=O)=O)NC([C@@H](NC([C@H](C(C)C)NC(C)=O)=O)CCC(O)=O)=O)C–Neurological Disease– H2O : 1 mg/mL (ultrasonic;warming)–Caspase–Caspase 3;Caspase 6;Caspase 7–Apoptosis–Peptides